1. Home
  2. RPID vs ONL Comparison

RPID vs ONL Comparison

Compare RPID & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPID
  • ONL
  • Stock Information
  • Founded
  • RPID 2006
  • ONL 2021
  • Country
  • RPID United States
  • ONL United States
  • Employees
  • RPID N/A
  • ONL N/A
  • Industry
  • RPID Medical Specialities
  • ONL Real Estate Investment Trusts
  • Sector
  • RPID Health Care
  • ONL Real Estate
  • Exchange
  • RPID Nasdaq
  • ONL Nasdaq
  • Market Cap
  • RPID 138.9M
  • ONL 119.7M
  • IPO Year
  • RPID 2021
  • ONL N/A
  • Fundamental
  • Price
  • RPID $2.85
  • ONL $2.79
  • Analyst Decision
  • RPID Strong Buy
  • ONL Hold
  • Analyst Count
  • RPID 2
  • ONL 1
  • Target Price
  • RPID $8.00
  • ONL N/A
  • AVG Volume (30 Days)
  • RPID 105.5K
  • ONL 384.5K
  • Earning Date
  • RPID 08-12-2025
  • ONL 08-06-2025
  • Dividend Yield
  • RPID N/A
  • ONL 2.93%
  • EPS Growth
  • RPID N/A
  • ONL N/A
  • EPS
  • RPID N/A
  • ONL N/A
  • Revenue
  • RPID $30,289,000.00
  • ONL $151,869,000.00
  • Revenue This Year
  • RPID $17.94
  • ONL N/A
  • Revenue Next Year
  • RPID $20.55
  • ONL N/A
  • P/E Ratio
  • RPID N/A
  • ONL N/A
  • Revenue Growth
  • RPID 22.57
  • ONL N/A
  • 52 Week Low
  • RPID $0.80
  • ONL $1.46
  • 52 Week High
  • RPID $4.50
  • ONL $4.39
  • Technical
  • Relative Strength Index (RSI)
  • RPID 43.63
  • ONL 68.43
  • Support Level
  • RPID $2.40
  • ONL $2.52
  • Resistance Level
  • RPID $3.59
  • ONL $2.88
  • Average True Range (ATR)
  • RPID 0.29
  • ONL 0.12
  • MACD
  • RPID -0.05
  • ONL 0.01
  • Stochastic Oscillator
  • RPID 35.16
  • ONL 78.41

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

About ONL Orion Office REIT Inc.

Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.

Share on Social Networks: